CLINICAL OUTCOMES OF MONO-THERAPY VERSUS DUAL ANTIHYPERTENSIVE THERAPY IN PATIENTS PRESENTING AT TEHSIL HOSPITAL IN PAKISTAN

J HUSSAIN; R ALTAF; A SHAKOOR; M ASHRAF; I MANSHA; F ASIM

doi:10.54112/bcsrj.v2024i1.1139

Authors

J HUSSAIN Department of Cardiology Sheikh Zayed Hospital Rahim Yar Khan, Pakistan
R ALTAF School of Pharmacy, University of Management and Technology, Lahore, Pakistan
A SHAKOOR Saidu group of Teaching Hospital, Saidu Sharif, Swat, Pakistan
M ASHRAF Department of Accident And Emergency, Abbasi Shaheed Hospital, Karachi, Pakistan
I MANSHA Faculty of Pharmacy, Hajvery University, Lahore, Pakistan
F ASIM Faculty of Pharmacy, The University of Lahore, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1139

Keywords:

Hypertension, IHD, DM

Abstract

Hypertension, a prevalent and potentially life-threatening condition, remains a significant public health concern in Pakistan. This article aims to investigate and compare the clinical outcomes of antihypertensive monotherapy versus combination therapy in patients treated at Tehsil Hospital, a critical healthcare facility in the Tehsil region of Pakistan. Objective: To assess and compare the clinical outcomes of hypertensive patients treated with monotherapy and those receiving a combination of antihypertensive medications at Tehsil Hospital, Pakistan. Methods: The study was carried out at Tehsil Hospital, Punjab-Pakistan. All adult participants (30 ≥ and ≤70 years) who were on antihypertensive medicine for at least 6 weeks and were diagnosed as hypertensive (average blood pressure of >140/90 mm Hg on at least two clinic visits) were included in the study from April 11 to June 20, 2022. The data was analyzed by SPSS 20. Statistical tests like chi-square were applied to obtain the required results. Results: A total of 136 study subjects were enrolled. Out of these, 113(81%) were male subjects, 23(17%) were female, 12(17.6%) smokers, and patients suffering from chronic liver disease were as 26(38.2%) treated with mono-therapy as compared with dual therapy with significant p-value 0.00 and 0.001. Other co-morbidities like the previous history of IHD, DM, and chronic kidney disease were treated with both therapies with insignificant p-values as > 0.05. Clinical outcomes were observed, and it was shown that more patients with stroke were treated with mono-therapy as p-value > 0.05 while comparing with major bleeding and control of hypertension showed a significant p-value of <0.05. Conclusion: Treatments in combination are effective and advised. The most important element in the management of hypertension, irrespective of whether medication is utilized, the goal is to get blood pressure down to the desired amount. Effective communication is essential for doctors, other healthcare professionals, and patients to treat patients.

Downloads

Download data is not yet available.

References

Qurrat-Ul-Ain Q-U-A. Patient and Doctor Perceptions of Hypertension and its Treatment: A Qualitative Study in Urban Hospitals of Pakistan. 2019.

Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart disease and stroke statistics—2022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153-e639.

Lewington S, Lacey B, Clarke R, Guo Y, Kong XL, Yang L, et al. The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA internal medicine. 2016;176(4):524-32.

Young V, Rajeswaran S, editors. Management of portal hypertension in the pediatric population: a primer for the interventional radiologist. Seminars in interventional radiology; 2018: Thieme Medical Publishers.

Organization WH. Global report on hypertension: the race against a silent killer: World Health Organization; 2023.

Shah N, Shah Q, Shah AJ. The burden and high prevalence of hypertension in Pakistani adolescents: a meta-analysis of the published studies. Archives of public health. 2018;76:1-10.

Riaz M, Shah G, Asif M, Shah A, Adhikari K, Abu-Shaheen A. Factors associated with hypertension in Pakistan: A systematic review and meta-analysis. PloS one. 2021;16(1):e0246085.

Xu X, Bao H, Tian Z, Zhu H, Zhu L, Niu L, et al. Prevalence, awareness, treatment, and control of hypertension in Northern China: a cross-sectional study. BMC Cardiovascular Disorders. 2021;21:1-11.

Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. Journal of the American college of cardiology. 2017;70(1):1-25.

Almas A, ur Rehman Iqbal S, Ehtamam A, Khan AH. Spectrum of antihypertensive therapy in South Asians at a tertiary care hospital in Pakistan. BMC research notes. 2011;4:1-6.

Yousuf FS, Khan MAA, Bibi R, Arif A, Arshad A, Almas A. MEDICATION ADHERENCE IN PATIENTS WITH UNCONTROLLED HYPERTENSION AND HYPERTENSIVE CRISIS PRESENTING TO AN HOSPITAL SETTING IN KARACHI, PAKISTAN. Journal of Hypertension. 2023;41(Suppl 3):e136.